Acquisition target ArthroCare moves into Spinal market
This article was originally published in Clinica
ArthroCare is to move into the $1 billion spinal surgery market with the European launch of its Coblation tools which use radiofrequency energy to remove tissue. The introduction of its products comes amid increased speculation that ArthroCare may be an acquisition target for a major company. ArthroCare's shares rose to a 52-week high of $62 on the news.